Encompass Health price target raised to $82 from $77 at Mizuho

Mizuho analyst Ann Hynes raised the firm’s price target on Encompass Health to $82 from $77 and keeps a Buy rating on the shares. The analyst increased estimates post the Q4 report. Given the strong fundamentals in the inpatient rehabilitation business, continued improvement in labor trends, bed expansion strategy and acquisition, the visibility is strong for Encompass, the analyst tells investors in a research note.